[1] Wei, C.J., Boyington, J.C., Dai, K., Houser, K.V., Pearce, M.B., Kong, W.P., Yang, Z.Y., Tumpey, T.M., and Nabel, G.J. (2010). Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design.
Sci Transl Med 2, 24ra21.
[2] Xu, R., Ekiert, D.C., Krause, J.C., Hai, R., Crowe, J.E., Jr., and Wilson, I.A. (2010). Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.
Science 328, 357–360 .
10.1126/science.1186430[3] Yang, H., Carney, P., and Stevens, J. (2010). Structure and receptor binding properties of a pandemic H1N1 virus hemagglutinin.
PLoS Curr Influenza RRN1152 .
[4] Zhang, W., Qi, J., Shi, Y., Li, Q., Gao, F., Sun, Ye., Lu, Xi., Lu, Q., Vavricka, C.J., Liu, D.,
. (2010). Crystal structure of the swine-origin A (H1N1) — 2009 influenza A virus hemagglutinin (HA) reveals similar antigenicity to that of the 1918 pandemic virus.
Protein Cell 1.
